CTI Biopharma reported $733K in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
Baxter International USD 2.23B 228M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Geron USD 116.64M 21.21M Dec/2025
Incyte USD 101.06M 17.61M Dec/2025
Novartis USD 6.42B 114M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Plus Therapeutics USD 107K 0 Sep/2020